• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

认知药理学：神经精神疾病的万能药？

Pharmacology of cognition: a panacea for neuropsychiatric disease?

机构信息

Drug and Target Discovery, Department of Pharmacy and Pharmacology, University of Bath, Bath, UK.

Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, University of Manchester, Manchester, UK.

出版信息

Br J Pharmacol. 2017 Oct;174(19):3133-3135. doi: 10.1111/bph.13956.

DOI:10.1111/bph.13956
PMID:28901012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5595767/
Abstract

This article is part of a themed section on Pharmacology of Cognition: a Panacea for Neuropsychiatric Disease? To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.19/issuetoc.

摘要

本文是认知药理学专题的一部分

神经精神疾病的万能药？要查看本专题中的其他文章，请访问 http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.19/issuetoc.。

相似文献

1
Pharmacology of cognition: a panacea for neuropsychiatric disease?认知药理学：神经精神疾病的万能药？
Br J Pharmacol. 2017 Oct;174(19):3133-3135. doi: 10.1111/bph.13956.
2
Targeting inflammation to reduce cardiovascular disease risk.针对炎症以降低心血管疾病风险。
Br J Pharmacol. 2017 Nov;174(22):3895-3897. doi: 10.1111/bph.14039.
3
Neurosteroid biosynthesis down-regulation and changes in GABA receptor subunit composition: a biomarker axis in stress-induced cognitive and emotional impairment.神经甾体生物合成下调和 GABA 受体亚基组成变化：应激诱导的认知和情绪障碍的生物标志物轴。
Br J Pharmacol. 2017 Oct;174(19):3226-3241. doi: 10.1111/bph.13843. Epub 2017 Jun 14.
4
Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research.谷氨酸能调节认知和功能脑连接：来自精神分裂症药理学、遗传学和转化研究的见解。
Br J Pharmacol. 2017 Oct;174(19):3136-3160. doi: 10.1111/bph.13919. Epub 2017 Aug 11.
5
Cross-species studies of cognition relevant to drug discovery: a translational approach.跨物种认知研究与药物发现：一种转化方法。
Br J Pharmacol. 2017 Oct;174(19):3191-3199. doi: 10.1111/bph.13826. Epub 2017 May 24.
6
Updating neuropathology and neuropharmacology of monoaminergic systems.单胺能系统神经病理学与神经药理学的更新
Br J Pharmacol. 2016 Jul;173(13):2065-8. doi: 10.1111/bph.13508.
7
Cognitive deficits caused by prefrontal cortical and hippocampal neural disinhibition.前额叶皮质和海马神经去抑制引起的认知缺陷。
Br J Pharmacol. 2017 Oct;174(19):3211-3225. doi: 10.1111/bph.13850. Epub 2017 Jun 7.
8
Lifestyle use of drugs by healthy people for enhancing cognition, creativity, motivation and pleasure.健康人出于改善认知、激发创造力、提高动机和获得愉悦感等目的而将药物作为生活方式使用。
Br J Pharmacol. 2017 Oct;174(19):3257-3267. doi: 10.1111/bph.13813. Epub 2017 May 12.
9
Recent developments in research of melatonin and its potential therapeutic applications.褪黑素研究的最新进展及其潜在的治疗应用。
Br J Pharmacol. 2018 Aug;175(16):3187-3189. doi: 10.1111/bph.14371.
10
WNT signalling: mechanisms and therapeutic opportunities.WNT 信号通路：机制与治疗机会。
Br J Pharmacol. 2017 Dec;174(24):4543-4546. doi: 10.1111/bph.14065.

引用本文的文献

1
Potential Role of Antipsychotic-Galantamine-Memantine Combination in the Treatment of Positive, Cognitive, and Negative Symptoms of Schizophrenia.抗精神病药物-加兰他敏-美金刚联合用药在治疗精神分裂症阳性、认知及阴性症状中的潜在作用
Mol Neuropsychiatry. 2018 Dec;4(3):134-148. doi: 10.1159/000494495. Epub 2018 Nov 19.

本文引用的文献

1
Using the affective bias test to predict drug-induced negative affect: implications for drug safety.使用情感偏见测试预测药物引起的负面情绪：对药物安全性的影响。
Br J Pharmacol. 2017 Oct;174(19):3200-3210. doi: 10.1111/bph.13972. Epub 2017 Aug 30.
2
Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies.将精神分裂症分子基础研究的进展转化为新的认知治疗策略。
Br J Pharmacol. 2017 Oct;174(19):3173-3190. doi: 10.1111/bph.13938. Epub 2017 Aug 3.
3
Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research.谷氨酸能调节认知和功能脑连接：来自精神分裂症药理学、遗传学和转化研究的见解。
Br J Pharmacol. 2017 Oct;174(19):3136-3160. doi: 10.1111/bph.13919. Epub 2017 Aug 11.
4
Cognitive deficits caused by prefrontal cortical and hippocampal neural disinhibition.前额叶皮质和海马神经去抑制引起的认知缺陷。
Br J Pharmacol. 2017 Oct;174(19):3211-3225. doi: 10.1111/bph.13850. Epub 2017 Jun 7.
5
Symptomatic thinking: the current state of Phase III and IV clinical trials for cognition in schizophrenia.症状性思维：精神分裂症认知功能的Ⅲ期和Ⅳ期临床试验现状
Drug Discov Today. 2017 Jul;22(7):1017-1026. doi: 10.1016/j.drudis.2017.04.014. Epub 2017 Apr 29.
6
Neurosteroid biosynthesis down-regulation and changes in GABA receptor subunit composition: a biomarker axis in stress-induced cognitive and emotional impairment.神经甾体生物合成下调和 GABA 受体亚基组成变化：应激诱导的认知和情绪障碍的生物标志物轴。
Br J Pharmacol. 2017 Oct;174(19):3226-3241. doi: 10.1111/bph.13843. Epub 2017 Jun 14.
7
Cross-species studies of cognition relevant to drug discovery: a translational approach.跨物种认知研究与药物发现：一种转化方法。
Br J Pharmacol. 2017 Oct;174(19):3191-3199. doi: 10.1111/bph.13826. Epub 2017 May 24.
8
Lifestyle use of drugs by healthy people for enhancing cognition, creativity, motivation and pleasure.健康人出于改善认知、激发创造力、提高动机和获得愉悦感等目的而将药物作为生活方式使用。
Br J Pharmacol. 2017 Oct;174(19):3257-3267. doi: 10.1111/bph.13813. Epub 2017 May 12.
9
Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders.大麻二酚对情绪和情绪记忆处理的调节：在治疗焦虑相关和物质滥用障碍中的相关性。
Br J Pharmacol. 2017 Oct;174(19):3242-3256. doi: 10.1111/bph.13724. Epub 2017 Mar 9.
10
The pro-cognitive mechanisms of physical exercise in people with schizophrenia.体育锻炼对精神分裂症患者认知能力的促进作用及其机制。
Br J Pharmacol. 2017 Oct;174(19):3161-3172. doi: 10.1111/bph.13772. Epub 2017 Apr 20.